Table 2.
Outcome variables | Control N=38 | Intervention N=47 | P-value |
---|---|---|---|
Secondary outcome variables | |||
No of patients with COPD exacerbations with hospitalization or ER visit | 20 (52.6%) | 19 (40.4%) | 0.262 |
No of patients with COPD exacerbations ER visit | 14 (36.8%) | 9 (19.1%) | 0.068 |
No of patients with COPD exacerbations hospitalization | 16 (42.1%) | 12 (25.5%) | 0.106 |
No of patients who needed antibiotics | 18 (47.4%) | 27 (56.3%) | 0.306 |
No of patients who needed glucocorticoids | 17 (44.7%) | 18 (37.5%) | 0.413 |
Days of hospital stay due to respiratory cause, mean ± SD | 12.4±7.1 | 9.3±6.4 | 0.154 |
All-cause mortality | 2 (5.26%) | 0 | 0.191 |
Primary outcome variables | |||
No COPD exacerbations with hospitalization or A&E visit | 52 | 42 | |
Days at risk | 3,801 | 4,700 | |
Rate of exacerbations with hospitalization or A&E visit, n (range) | 1.37 (1.02–1.79) | 0.89 (0.64–1.21) | 0.049 |
Rate ratio, n (range) | 1.53 (1.01–2.29) |
Abbreviation: SD, standard deviation.